Cargando…

The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient

Adenovirus is an important cause of haemorrhagic cystitis in kidney transplant recipients. The optimal treatment for adenovirus-associated haemorrhagic cystitis (AAHC) is unknown. Intravenous cidofovir may be effective, but nephrotoxicity is a major concern. The use of intravesical cidofovir for vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Quan Yao, Tan, Chieh Suai, Thien, Siew Yee, Kee, Terence, Chlebicki, Maciej Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768302/
https://www.ncbi.nlm.nih.gov/pubmed/31583099
http://dx.doi.org/10.1093/ckj/sfz016
_version_ 1783455080031191040
author Ho, Quan Yao
Tan, Chieh Suai
Thien, Siew Yee
Kee, Terence
Chlebicki, Maciej Piotr
author_facet Ho, Quan Yao
Tan, Chieh Suai
Thien, Siew Yee
Kee, Terence
Chlebicki, Maciej Piotr
author_sort Ho, Quan Yao
collection PubMed
description Adenovirus is an important cause of haemorrhagic cystitis in kidney transplant recipients. The optimal treatment for adenovirus-associated haemorrhagic cystitis (AAHC) is unknown. Intravenous cidofovir may be effective, but nephrotoxicity is a major concern. The use of intravesical cidofovir for viral haemorrhagic cystitis has been reported in haematopoietic stem cell transplant recipients and may be associated with a lower risk of nephrotoxicity, but its use has not been reported in kidney transplant recipients. We report the use of intravesical cidofovir for the treatment of AAHC in a kidney transplant recipients, along with a review of the literature.
format Online
Article
Text
id pubmed-6768302
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67683022019-10-03 The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient Ho, Quan Yao Tan, Chieh Suai Thien, Siew Yee Kee, Terence Chlebicki, Maciej Piotr Clin Kidney J Transplantation Adenovirus is an important cause of haemorrhagic cystitis in kidney transplant recipients. The optimal treatment for adenovirus-associated haemorrhagic cystitis (AAHC) is unknown. Intravenous cidofovir may be effective, but nephrotoxicity is a major concern. The use of intravesical cidofovir for viral haemorrhagic cystitis has been reported in haematopoietic stem cell transplant recipients and may be associated with a lower risk of nephrotoxicity, but its use has not been reported in kidney transplant recipients. We report the use of intravesical cidofovir for the treatment of AAHC in a kidney transplant recipients, along with a review of the literature. Oxford University Press 2019-02-18 /pmc/articles/PMC6768302/ /pubmed/31583099 http://dx.doi.org/10.1093/ckj/sfz016 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Transplantation
Ho, Quan Yao
Tan, Chieh Suai
Thien, Siew Yee
Kee, Terence
Chlebicki, Maciej Piotr
The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
title The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
title_full The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
title_fullStr The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
title_full_unstemmed The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
title_short The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
title_sort use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient
topic Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768302/
https://www.ncbi.nlm.nih.gov/pubmed/31583099
http://dx.doi.org/10.1093/ckj/sfz016
work_keys_str_mv AT hoquanyao theuseofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT tanchiehsuai theuseofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT thiensiewyee theuseofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT keeterence theuseofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT chlebickimaciejpiotr theuseofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT hoquanyao useofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT tanchiehsuai useofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT thiensiewyee useofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT keeterence useofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient
AT chlebickimaciejpiotr useofintravesicalcidofovirforthetreatmentofadenovirusassociatedhaemorrhagiccystitisinakidneytransplantrecipient